Israel - Hebrew - Ministry of Health

rafa laboratories ltd - minocycline as hydrochloride - קפסולות - minocycline as hydrochloride 50 mg - minocycline - minocycline - treatment of infections caused by tetracycline sensitive organisms, including acne, gonnorrhea and prophylaxis of asymptomatic meningococcal carrier.

Israel - Hebrew - Ministry of Health

rafa laboratories ltd - minocycline as hydrochloride - קפסולות - minocycline as hydrochloride 100 mg - minocycline - minocycline - treatment of infections caused by minocycline-sensitive micro-organisms including acne, gonorrhea and prophylaxis of asymptomatic meningococcal carrie.

Israel - Hebrew - Ministry of Health

novartis israel ltd - ciclosporin - תמיסה לאינפוזיה - ciclosporin 50 mg/ml - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation.

Israel - Hebrew - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 25 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Hebrew - Ministry of Health

novartis israel ltd - ciclosporin - תמיסה - ciclosporin 100 mg/ml - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment.atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Hebrew - Ministry of Health

dexcel ltd, israel - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Hebrew - Ministry of Health

dexcel ltd, israel - ciclosporin - קפסולות - ciclosporin 25 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Hebrew - Ministry of Health

dexcel ltd, israel - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney, liver, heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejections in patients previously treated with other immunosuppresive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that does not respond to other treatment . atopic dermatitis in adults only up to 8 weeks, for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis, severe cases when standard treatment is ineffective or inappropriate. nephrotic syndrome type mcd (minimal change disease) in cases where conventional therapy has failed.

Israel - Hebrew - Ministry of Health

tec-o-pharm-libra ltd - bupivacaine hydrochloride 5 mg/ml; epinephrine as tartrate 5.5 mcg/ml - solution for injection - bupivacaine - nerve blocks of long duration where substantial muscle relaxation is not a requirement e.g. in obstetrics, for postoperative pain relief and also therapeutic and diagnostic blocks.

Israel - Hebrew - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 50 mg/vial - enzymes - acute myocardial infarction in adults for the lysis of thrombi obstructing coronary arteries the improvement of ventricular function and reduction of the incidence of congestive heart failure. pulmonary embolism with hemodynamic deprivation. for fibrinolytic treatment of acute ischaemic stroke. treatment must be started within 3 hours of onset of the stroke symptoms and after prior exclusion of intracranial haemorrhage by means of appropriate imaging techniques.this treatment is restricted to a prescription by aspecialist in neurology.